Lupin Ltd. Sees Significant Open Interest Surge Signalling Bullish Market Positioning

Open Interest and Volume Dynamics

The latest data reveals that Lupin’s open interest (OI) in derivatives has risen sharply to 27,542 contracts, up 11.44% from the previous figure of 24,715. This increase of 2,827 contracts is significant, indicating fresh positions being established or existing ones being rolled over. Concurrently, the trading volume stood at 41,807 contracts, underscoring heightened activity in the stock’s futures and options market.

In monetary terms, the futures segment recorded a value of approximately ₹44,196 lakhs, while the options segment exhibited an astronomical notional value of ₹35,529.96 crores, culminating in a total derivatives turnover of ₹50,577.39 lakhs. Such elevated figures highlight Lupin’s liquidity and attractiveness among derivatives traders.

Price Performance and Market Positioning

Lupin’s underlying share price closed at ₹2,205, having touched an intraday high of ₹2,226.3, a gain of 3.56% on the day. The stock has outperformed its sector by 1.99% and the broader Sensex by a considerable margin, with a 1-day return of 2.15% compared to the sector’s 0.49% and Sensex’s marginal decline of 0.13%. Notably, Lupin has been on a two-day winning streak, delivering cumulative returns of 5.81% during this period.

The stock is trading comfortably above all key moving averages — 5-day, 20-day, 50-day, 100-day, and 200-day — signalling a strong uptrend and positive technical momentum. This technical strength is further corroborated by a surge in delivery volumes, which on 6 January reached 14.65 lakh shares, a remarkable 230.12% increase over the five-day average delivery volume, indicating genuine investor participation rather than speculative intraday trading.

Implications of Rising Open Interest

The sharp rise in open interest alongside increasing volumes typically suggests that new money is flowing into the stock, with traders taking fresh positions rather than merely squaring off existing ones. This often precedes sustained price moves, as it reflects conviction in the underlying trend. In Lupin’s case, the increase in OI by over 11% within a single session points to a growing bullish bias among market participants.

Given the stock’s recent upgrade from a Hold to a Buy rating by MarketsMOJO on 12 November 2025, with a Mojo Score of 74.0, investor confidence appears to be strengthening. The upgrade was driven by improved fundamentals and positive sectoral outlook, which now seem to be translating into tangible market action.

Market Liquidity and Investor Participation

Lupin’s market cap stands at a robust ₹1,00,557 crore, categorising it as a large-cap stock with substantial institutional and retail interest. The stock’s liquidity is also noteworthy, with the ability to handle trade sizes of approximately ₹3.41 crore based on 2% of the five-day average traded value, making it accessible for sizeable trades without significant price impact.

The surge in delivery volumes and consistent price appreciation over recent sessions suggest that investors are increasingly favouring Lupin as a core portfolio holding. This is supported by the stock’s strong fundamentals and positive sector outlook, which have been recognised in its recent Mojo Grade upgrade from Hold to Buy.

Derivatives Market Positioning and Directional Bets

The derivatives market activity reveals a clear tilt towards bullish positioning. The increase in open interest combined with rising futures and options volumes indicates that traders are likely placing directional bets anticipating further upside. The futures value of ₹44,196 lakhs and the massive options notional value suggest active hedging and speculative strategies are in play.

Options data, although not detailed here, typically complements this narrative when call option open interest and volumes rise disproportionately compared to puts, signalling bullish sentiment. Given Lupin’s recent price strength and technical positioning, it is plausible that market participants are positioning for continued gains in the near term.

Sectoral Context and Outlook

The Pharmaceuticals & Biotechnology sector has been underpinned by steady demand, innovation in drug development, and favourable regulatory developments. Lupin, as a key player, benefits from these tailwinds, reflected in its improving fundamentals and market sentiment. The stock’s Mojo Score of 74.0 and Buy grade reflect a positive outlook, supported by strong earnings growth prospects and resilient business operations.

While the broader market has shown mixed performance, Lupin’s outperformance relative to the Sensex and its sector peers highlights its relative strength. Investors should, however, remain mindful of sector-specific risks such as regulatory changes, pricing pressures, and global supply chain challenges that could impact near-term performance.

Conclusion: A Bullish Signal with Cautious Optimism

The surge in Lupin’s open interest and volume in the derivatives market, coupled with strong price action and rising delivery volumes, signals a growing bullish consensus among market participants. The upgrade to a Buy rating and the stock’s technical strength further reinforce this positive outlook.

Investors and traders should monitor ongoing derivatives activity and price movements closely, as sustained increases in open interest alongside rising prices often precede further gains. However, prudent risk management remains essential given the inherent volatility in the pharmaceutical sector and broader market uncertainties.

Overall, Lupin Ltd. presents a compelling case for investors seeking exposure to a fundamentally strong and technically robust stock within the Pharmaceuticals & Biotechnology sector, supported by active market participation and positive sentiment in the derivatives space.

Upgrade at special rates, valid only for the next few days. Claim Your Special Rate →